The drug was shown to be as safe as placebo on a composite of CV death, nonfatal myocardial infarction or nonfatal strokeOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.